Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Sep 30;15(9):e0009287.
doi: 10.1371/journal.pntd.0009287. eCollection 2021 Sep.

Multiphase evaluation of portable medicines quality screening devices

Céline Caillet  1   2   3   4 , Serena Vickers  1   2   3 , Stephen Zambrzycki  5 , Nantasit Luangasanatip  4 , Vayouly Vidhamaly  1   2   3 , Kem Boutsamay  1   2   3 , Phonepasith Boupha  1   2   3 , Yoel Lubell  2   4 , Facundo M Fernández  5 , Paul N Newton  1   2   3   4
Affiliations
Editorial

Multiphase evaluation of portable medicines quality screening devices

Céline Caillet et al. PLoS Negl Trop Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Diagram of the outline for the overall project.
$ The CoDI (developed by the United States CDC)—a device that uses laser absorption and fluorescence—could not be assessed because of intellectual property issues. A misunderstanding of the operational procedures of the CD3+—a device using UV-Vis-IR light to reveal differences in the packaging as compared to its genuine counterpart (developed by the US FDA)—led to potential significant bias in the performance results of the device during its evaluation. Those are thus not presented in this article. CDC, Centers for Disease Control and Prevention; CoDI, Counterfeit Detection Indicator; FDA, Food and Drug Administration.
See this image and copyright information in PMC

References

    1. Newton PN, Caillet C. Guerin PJ. A link between poor quality antimalarials and malaria drug resistance?. 2016;14(6):531–3. doi: 10.1080/14787210.2016.1187560 - DOI - PubMed
    1. SF Medical Products Group, Essential Medicines and Health Products WHO. WHO Member State Mechanism on Substandard/Spurious/Falsely-Labelled/Falsified/Counterfeit (SSFFC) Medical Products. In: Seventieth World Health Assembly; [Internet]. Geneva, Switzerland; 2017. p. A70/23: 33–36. Available from: http://www.who.int/medicines/regulation/ssffc/A70_23-en1.pdf?ua=1.
    1. World Health Organization. WHO Global Surveillance and Monitoring System for substandard and falsified medical products: executive summary. [Internet]. Geneva, Switzerland; 2017. Available from: https://www.who.int/medicines/regulation/ssffc/publications/gsms-report-....
    1. Tivura M, Asante I, van Wyk A, Gyaase S, Malik N, Mahama E, et al.. Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use. BMC Pharmacol Toxicol. 2016;17(1):48. doi: 10.1186/s40360-016-0089-2 - DOI - PMC - PubMed
    1. Wafula F, Dolinger A, Daniels B, Mwaura N, Bedoya G, Rogo K, et al.. Examining the Quality of Medicines at Kenyan Healthcare Facilities: A Validation of an Alternative Post-Market Surveillance Model That Uses Standardized Patients. Drugs Real World Outcomes. 2016;4(1):53–63. - PMC - PubMed

Publication types

MeSH terms